Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hao Zhang
University of Wisconsin Madison, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Opticent Health
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research is related to the focus of an entity in which Professor Zhang has significant financial interests, Opticent Health. Opticent Health is working to produce a next generation Optical Coherence Tomography (OCT) device with improved resolution over existing devices and the ability to determine functional information about imaged vasculature. Opticent Health is also working on high resolution fabrication and the design and manufacture of optical medical devices tailored for individual patients, providing better performance and a host of novel features over existing devices.
This research involves multimodal retinal imaging and photoacoustic ophthalmoscopy (PAOM) being integrated with spectral-domain optical coherence tomography (SD-OCT).
The close intersection of this research and Professor Zhang’s Opticent Health’s interests, particularly relative to OCT, results in the perception of a conflict of interest that should be managed
Novel Antiangiogenic Peptides for Treatment of Exudative AMD
Identification of effective compounds that can arrest the disease state with minimal systemic side effects, and alleviate the necessity of repeated intravitreal delivery is vital for effective treatment of AMD. Utilizing a mechanistically relevant model of AMD, we have demonstrated rapid screening to test a broad set of novel peptide molecules. This proposal offers a compelling opportunity to attack exudative AMD.
Filed on June 09, 2015.
Tell us what you know about Hao Zhang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Hao Zhang”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hao Zhang | Northwestern University | Conflict of Interest | Opticent Health | Value cannot be readily determined |
| Hao Zhang | Northwestern University at Chicago | Conflict of Interest | Opticent Health | Value cannot be readily determined |
| Hao Zhang | Northwestern University | Conflict of Interest | Opticent Health | Value cannot be readily determined |
| Hao Zhang | Florida International University | Conflict of Interest | Opticent Health | Value cannot be readily determined |
| Hao Zhang | Northwestern University | Conflict of Interest | Opticent Health | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.